# ADENOSINE

NDC: 51662-1631
Generic name: ADENOSINE
Labeler / Manufacturer: HF Acquisition Co LLC, DBA HealthFirst
Product type: HUMAN PRESCRIPTION DRUG
Marketing category: Abbreviated NDA (generic)
Dosage form: INJECTION
Routes: INTRAVENOUS
Marketing started: 20230428

FDA application: ANDA078686

## Active ingredients

- ADENOSINE: 3 mg/mL

## Pharmacological class

—

## External sources

- openFDA: https://api.fda.gov/drug/ndc.json?search=product_ndc:"51662-1631"
- FDA NDC Directory: https://www.accessdata.fda.gov/scripts/cder/ndc/dsp_searchresult.cfm?p_ndc=51662-1631
- DailyMed: https://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=fa6eb0f8-7c41-2e17-e053-6294a90ac8ca